ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pharmaceutics and Novel Drug Delivery Systems Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-13W9949
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Pharmaceutics and Novel Drug Delivery Systems Market Insights Forecast to 2028
BUY CHAPTERS

Global Pharmaceutics and Novel Drug Delivery Systems Market Insights, Forecast to 2030

Code: QYRE-Auto-13W9949
Report
December 2024
Pages:125
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Amgen Inc
TEVA
Roche
UCB (Union Chimique Belge)
Celgene
Merck
Gilead Sciences
Sanofi
Pfizer Inc
Takeda
Bausch & Lomb
Samyang Biopharmaceuticals
Johnson & Johnson
Tolmar
Astellas
AMAG Pharmaceuticals
AbbVie
Dr. Reddy
Astrazeneca plc
Aspen
Acrotech Biopharma
TWi Pharmaceuticals

Pharmaceutics and Novel Drug Delivery Systems Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Pharmaceutics and Novel Drug Delivery Systems Market

Pharmaceutics and Novel Drug Delivery Systems Market

Novel drug delivery is a method of delivering medication to a patient in a manner that increases the concentration of the medication in some parts of the body relative to others.
Market Analysis and Insights: Global Pharmaceutics and Novel Drug Delivery Systems Market
The global Pharmaceutics and Novel Drug Delivery Systems market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Pharmaceutics and Novel Drug Delivery Systems market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Pharmaceutics and Novel Drug Delivery Systems, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Pharmaceutics and Novel Drug Delivery Systems, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Pharmaceutics and Novel Drug Delivery Systems revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Pharmaceutics and Novel Drug Delivery Systems market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Pharmaceutics and Novel Drug Delivery Systems revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Pharmaceutics and Novel Drug Delivery Systems Market Report

Report Metric Details
Report Name Pharmaceutics and Novel Drug Delivery Systems Market
CAGR 5%
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Amgen, Teva, Roche, UCB (Union Chimique Belge), Celgene, Merck, Gilead Sciences, Sanofi, Pfizer, Takeda, Bausch&Lomb, Samyang Biopharmaceuticals, Johnson & Johnson, TOLMAR, Astellas, AMAG Pharmaceuticals, AbbVie, Dr Reddy, AstraZeneca, Aspen, Acrotech Biopharma, TWi Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Revenue of Pharmaceutics and Novel Drug Delivery Systems in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Pharmaceutics and Novel Drug Delivery Systems companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 8: China by Type, and by Application, revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pharmaceutics and Novel Drug Delivery Systems revenue, gross margin, and recent development, etc.
  • Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

Who are the main players in the Pharmaceutics and Novel Drug Delivery Systems Market report?

Ans: The main players in the Pharmaceutics and Novel Drug Delivery Systems Market are Amgen, Teva, Roche, UCB (Union Chimique Belge), Celgene, Merck, Gilead Sciences, Sanofi, Pfizer, Takeda, Bausch&Lomb, Samyang Biopharmaceuticals, Johnson & Johnson, TOLMAR, Astellas, AMAG Pharmaceuticals, AbbVie, Dr Reddy, AstraZeneca, Aspen, Acrotech Biopharma, TWi Pharmaceuticals

What are the Application segmentation covered in the Pharmaceutics and Novel Drug Delivery Systems Market report?

Ans: The Applications covered in the Pharmaceutics and Novel Drug Delivery Systems Market report are Hospitals & Clinic, Cancer Treatment Centers, Others

What are the Type segmentation covered in the Pharmaceutics and Novel Drug Delivery Systems Market report?

Ans: The Types covered in the Pharmaceutics and Novel Drug Delivery Systems Market report are Liposomes, PEGylated Proteins & Polypeptides, Polymer Nanoparticle, Protein–drug Conjugates, Other

Recommended Reports

Drug Delivery Systems

Pharmacy Automation

Oncology & Treatments

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmaceutics and Novel Drug Delivery Systems Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Liposomes
1.2.3 PEGylated Proteins & Polypeptides
1.2.4 Polymer Nanoparticle
1.2.5 Protein–drug Conjugates
1.2.6 Other
1.3 Market by Application
1.3.1 Global Pharmaceutics and Novel Drug Delivery Systems Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospitals & Clinic
1.3.3 Cancer Treatment Centers
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pharmaceutics and Novel Drug Delivery Systems Market Perspective (2019-2030)
2.2 Global Pharmaceutics and Novel Drug Delivery Systems Growth Trends by Region
2.2.1 Pharmaceutics and Novel Drug Delivery Systems Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Pharmaceutics and Novel Drug Delivery Systems Historic Market Size by Region (2019-2024)
2.2.3 Pharmaceutics and Novel Drug Delivery Systems Forecasted Market Size by Region (2025-2030)
2.3 Pharmaceutics and Novel Drug Delivery Systems Market Dynamics
2.3.1 Pharmaceutics and Novel Drug Delivery Systems Industry Trends
2.3.2 Pharmaceutics and Novel Drug Delivery Systems Market Drivers
2.3.3 Pharmaceutics and Novel Drug Delivery Systems Market Challenges
2.3.4 Pharmaceutics and Novel Drug Delivery Systems Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Pharmaceutics and Novel Drug Delivery Systems by Players
3.1.1 Global Pharmaceutics and Novel Drug Delivery Systems Revenue by Players (2019-2024)
3.1.2 Global Pharmaceutics and Novel Drug Delivery Systems Revenue Market Share by Players (2019-2024)
3.2 Global Pharmaceutics and Novel Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Pharmaceutics and Novel Drug Delivery Systems, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Pharmaceutics and Novel Drug Delivery Systems Market Concentration Ratio
3.4.1 Global Pharmaceutics and Novel Drug Delivery Systems Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmaceutics and Novel Drug Delivery Systems Revenue in 2023
3.5 Global Key Players of Pharmaceutics and Novel Drug Delivery Systems Head office and Area Served
3.6 Global Key Players of Pharmaceutics and Novel Drug Delivery Systems, Product and Application
3.7 Global Key Players of Pharmaceutics and Novel Drug Delivery Systems, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharmaceutics and Novel Drug Delivery Systems Breakdown Data by Type
4.1 Global Pharmaceutics and Novel Drug Delivery Systems Historic Market Size by Type (2019-2024)
4.2 Global Pharmaceutics and Novel Drug Delivery Systems Forecasted Market Size by Type (2025-2030)
5 Pharmaceutics and Novel Drug Delivery Systems Breakdown Data by Application
5.1 Global Pharmaceutics and Novel Drug Delivery Systems Historic Market Size by Application (2019-2024)
5.2 Global Pharmaceutics and Novel Drug Delivery Systems Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Pharmaceutics and Novel Drug Delivery Systems Market Size (2019-2030)
6.2 North America Pharmaceutics and Novel Drug Delivery Systems Market Size by Type
6.2.1 North America Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2019-2024)
6.2.2 North America Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2025-2030)
6.2.3 North America Pharmaceutics and Novel Drug Delivery Systems Market Share by Type (2019-2030)
6.3 North America Pharmaceutics and Novel Drug Delivery Systems Market Size by Application
6.3.1 North America Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2019-2024)
6.3.2 North America Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2025-2030)
6.3.3 North America Pharmaceutics and Novel Drug Delivery Systems Market Share by Application (2019-2030)
6.4 North America Pharmaceutics and Novel Drug Delivery Systems Market Size by Country
6.4.1 North America Pharmaceutics and Novel Drug Delivery Systems Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Pharmaceutics and Novel Drug Delivery Systems Market Size by Country (2019-2024)
6.4.3 North America Pharmaceutics and Novel Drug Delivery Systems Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Pharmaceutics and Novel Drug Delivery Systems Market Size (2019-2030)
7.2 Europe Pharmaceutics and Novel Drug Delivery Systems Market Size by Type
7.2.1 Europe Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2019-2024)
7.2.2 Europe Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2025-2030)
7.2.3 Europe Pharmaceutics and Novel Drug Delivery Systems Market Share by Type (2019-2030)
7.3 Europe Pharmaceutics and Novel Drug Delivery Systems Market Size by Application
7.3.1 Europe Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2019-2024)
7.3.2 Europe Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2025-2030)
7.3.3 Europe Pharmaceutics and Novel Drug Delivery Systems Market Share by Application (2019-2030)
7.4 Europe Pharmaceutics and Novel Drug Delivery Systems Market Size by Country
7.4.1 Europe Pharmaceutics and Novel Drug Delivery Systems Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Pharmaceutics and Novel Drug Delivery Systems Market Size by Country (2019-2024)
7.4.3 Europe Pharmaceutics and Novel Drug Delivery Systems Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Pharmaceutics and Novel Drug Delivery Systems Market Size (2019-2030)
8.2 China Pharmaceutics and Novel Drug Delivery Systems Market Size by Type
8.2.1 China Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2019-2024)
8.2.2 China Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2025-2030)
8.2.3 China Pharmaceutics and Novel Drug Delivery Systems Market Share by Type (2019-2030)
8.3 China Pharmaceutics and Novel Drug Delivery Systems Market Size by Application
8.3.1 China Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2019-2024)
8.3.2 China Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2025-2030)
8.3.3 China Pharmaceutics and Novel Drug Delivery Systems Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Pharmaceutics and Novel Drug Delivery Systems Market Size (2019-2030)
9.2 Asia Pharmaceutics and Novel Drug Delivery Systems Market Size by Type
9.2.1 Asia Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2019-2024)
9.2.2 Asia Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2025-2030)
9.2.3 Asia Pharmaceutics and Novel Drug Delivery Systems Market Share by Type (2019-2030)
9.3 Asia Pharmaceutics and Novel Drug Delivery Systems Market Size by Application
9.3.1 Asia Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2019-2024)
9.3.2 Asia Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2025-2030)
9.3.3 Asia Pharmaceutics and Novel Drug Delivery Systems Market Share by Application (2019-2030)
9.4 Asia Pharmaceutics and Novel Drug Delivery Systems Market Size by Region
9.4.1 Asia Pharmaceutics and Novel Drug Delivery Systems Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Pharmaceutics and Novel Drug Delivery Systems Market Size by Region (2019-2024)
9.4.3 Asia Pharmaceutics and Novel Drug Delivery Systems Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Pharmaceutics and Novel Drug Delivery Systems Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Pharmaceutics and Novel Drug Delivery Systems Market Size by Type
10.2.1 Middle East, Africa, and Latin America Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Pharmaceutics and Novel Drug Delivery Systems Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Pharmaceutics and Novel Drug Delivery Systems Market Size by Application
10.3.1 Middle East, Africa, and Latin America Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Pharmaceutics and Novel Drug Delivery Systems Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Pharmaceutics and Novel Drug Delivery Systems Market Size by Country
10.4.1 Middle East, Africa, and Latin America Pharmaceutics and Novel Drug Delivery Systems Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Pharmaceutics and Novel Drug Delivery Systems Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Pharmaceutics and Novel Drug Delivery Systems Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Amgen
11.1.1 Amgen Company Details
11.1.2 Amgen Business Overview
11.1.3 Amgen Pharmaceutics and Novel Drug Delivery Systems Introduction
11.1.4 Amgen Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024)
11.1.5 Amgen Recent Developments
11.2 Teva
11.2.1 Teva Company Details
11.2.2 Teva Business Overview
11.2.3 Teva Pharmaceutics and Novel Drug Delivery Systems Introduction
11.2.4 Teva Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024)
11.2.5 Teva Recent Developments
11.3 Roche
11.3.1 Roche Company Details
11.3.2 Roche Business Overview
11.3.3 Roche Pharmaceutics and Novel Drug Delivery Systems Introduction
11.3.4 Roche Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024)
11.3.5 Roche Recent Developments
11.4 UCB (Union Chimique Belge)
11.4.1 UCB (Union Chimique Belge) Company Details
11.4.2 UCB (Union Chimique Belge) Business Overview
11.4.3 UCB (Union Chimique Belge) Pharmaceutics and Novel Drug Delivery Systems Introduction
11.4.4 UCB (Union Chimique Belge) Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024)
11.4.5 UCB (Union Chimique Belge) Recent Developments
11.5 Celgene
11.5.1 Celgene Company Details
11.5.2 Celgene Business Overview
11.5.3 Celgene Pharmaceutics and Novel Drug Delivery Systems Introduction
11.5.4 Celgene Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024)
11.5.5 Celgene Recent Developments
11.6 Merck
11.6.1 Merck Company Details
11.6.2 Merck Business Overview
11.6.3 Merck Pharmaceutics and Novel Drug Delivery Systems Introduction
11.6.4 Merck Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024)
11.6.5 Merck Recent Developments
11.7 Gilead Sciences
11.7.1 Gilead Sciences Company Details
11.7.2 Gilead Sciences Business Overview
11.7.3 Gilead Sciences Pharmaceutics and Novel Drug Delivery Systems Introduction
11.7.4 Gilead Sciences Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024)
11.7.5 Gilead Sciences Recent Developments
11.8 Sanofi
11.8.1 Sanofi Company Details
11.8.2 Sanofi Business Overview
11.8.3 Sanofi Pharmaceutics and Novel Drug Delivery Systems Introduction
11.8.4 Sanofi Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024)
11.8.5 Sanofi Recent Developments
11.9 Pfizer
11.9.1 Pfizer Company Details
11.9.2 Pfizer Business Overview
11.9.3 Pfizer Pharmaceutics and Novel Drug Delivery Systems Introduction
11.9.4 Pfizer Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024)
11.9.5 Pfizer Recent Developments
11.10 Takeda
11.10.1 Takeda Company Details
11.10.2 Takeda Business Overview
11.10.3 Takeda Pharmaceutics and Novel Drug Delivery Systems Introduction
11.10.4 Takeda Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024)
11.10.5 Takeda Recent Developments
11.11 Bausch&Lomb
11.11.1 Bausch&Lomb Company Details
11.11.2 Bausch&Lomb Business Overview
11.11.3 Bausch&Lomb Pharmaceutics and Novel Drug Delivery Systems Introduction
11.11.4 Bausch&Lomb Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024)
11.11.5 Bausch&Lomb Recent Developments
11.12 Samyang Biopharmaceuticals
11.12.1 Samyang Biopharmaceuticals Company Details
11.12.2 Samyang Biopharmaceuticals Business Overview
11.12.3 Samyang Biopharmaceuticals Pharmaceutics and Novel Drug Delivery Systems Introduction
11.12.4 Samyang Biopharmaceuticals Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024)
11.12.5 Samyang Biopharmaceuticals Recent Developments
11.13 Johnson & Johnson
11.13.1 Johnson & Johnson Company Details
11.13.2 Johnson & Johnson Business Overview
11.13.3 Johnson & Johnson Pharmaceutics and Novel Drug Delivery Systems Introduction
11.13.4 Johnson & Johnson Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024)
11.13.5 Johnson & Johnson Recent Developments
11.14 TOLMAR
11.14.1 TOLMAR Company Details
11.14.2 TOLMAR Business Overview
11.14.3 TOLMAR Pharmaceutics and Novel Drug Delivery Systems Introduction
11.14.4 TOLMAR Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024)
11.14.5 TOLMAR Recent Developments
11.15 Astellas
11.15.1 Astellas Company Details
11.15.2 Astellas Business Overview
11.15.3 Astellas Pharmaceutics and Novel Drug Delivery Systems Introduction
11.15.4 Astellas Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024)
11.15.5 Astellas Recent Developments
11.16 AMAG Pharmaceuticals
11.16.1 AMAG Pharmaceuticals Company Details
11.16.2 AMAG Pharmaceuticals Business Overview
11.16.3 AMAG Pharmaceuticals Pharmaceutics and Novel Drug Delivery Systems Introduction
11.16.4 AMAG Pharmaceuticals Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024)
11.16.5 AMAG Pharmaceuticals Recent Developments
11.17 AbbVie
11.17.1 AbbVie Company Details
11.17.2 AbbVie Business Overview
11.17.3 AbbVie Pharmaceutics and Novel Drug Delivery Systems Introduction
11.17.4 AbbVie Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024)
11.17.5 AbbVie Recent Developments
11.18 Dr Reddy
11.18.1 Dr Reddy Company Details
11.18.2 Dr Reddy Business Overview
11.18.3 Dr Reddy Pharmaceutics and Novel Drug Delivery Systems Introduction
11.18.4 Dr Reddy Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024)
11.18.5 Dr Reddy Recent Developments
11.19 AstraZeneca
11.19.1 AstraZeneca Company Details
11.19.2 AstraZeneca Business Overview
11.19.3 AstraZeneca Pharmaceutics and Novel Drug Delivery Systems Introduction
11.19.4 AstraZeneca Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024)
11.19.5 AstraZeneca Recent Developments
11.20 Aspen
11.20.1 Aspen Company Details
11.20.2 Aspen Business Overview
11.20.3 Aspen Pharmaceutics and Novel Drug Delivery Systems Introduction
11.20.4 Aspen Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024)
11.20.5 Aspen Recent Developments
11.21 Acrotech Biopharma
11.21.1 Acrotech Biopharma Company Details
11.21.2 Acrotech Biopharma Business Overview
11.21.3 Acrotech Biopharma Pharmaceutics and Novel Drug Delivery Systems Introduction
11.21.4 Acrotech Biopharma Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024)
11.21.5 Acrotech Biopharma Recent Developments
11.22 TWi Pharmaceuticals
11.22.1 TWi Pharmaceuticals Company Details
11.22.2 TWi Pharmaceuticals Business Overview
11.22.3 TWi Pharmaceuticals Pharmaceutics and Novel Drug Delivery Systems Introduction
11.22.4 TWi Pharmaceuticals Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024)
11.22.5 TWi Pharmaceuticals Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
FEATURED COMPANIES
Amgen Inc
TEVA
Roche
UCB (Union Chimique Belge)
Celgene
Merck
Gilead Sciences
Sanofi
Pfizer Inc
Takeda
Bausch & Lomb
Samyang Biopharmaceuticals
Johnson & Johnson
Tolmar
Astellas
AMAG Pharmaceuticals
AbbVie
Dr. Reddy
Astrazeneca plc
Aspen
Acrotech Biopharma
TWi Pharmaceuticals
List of Tables
    Table 1. Global Pharmaceutics and Novel Drug Delivery Systems Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Liposomes
    Table 3. Key Players of PEGylated Proteins & Polypeptides
    Table 4. Key Players of Polymer Nanoparticle
    Table 5. Key Players of Protein–drug Conjugates
    Table 6. Key Players of Other
    Table 7. Global Pharmaceutics and Novel Drug Delivery Systems Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 8. Global Pharmaceutics and Novel Drug Delivery Systems Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 9. Global Pharmaceutics and Novel Drug Delivery Systems Market Size by Region (2019-2024) & (US$ Million)
    Table 10. Global Pharmaceutics and Novel Drug Delivery Systems Market Share by Region (2019-2024)
    Table 11. Global Pharmaceutics and Novel Drug Delivery Systems Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 12. Global Pharmaceutics and Novel Drug Delivery Systems Market Share by Region (2025-2030)
    Table 13. Pharmaceutics and Novel Drug Delivery Systems Market Trends
    Table 14. Pharmaceutics and Novel Drug Delivery Systems Market Drivers
    Table 15. Pharmaceutics and Novel Drug Delivery Systems Market Challenges
    Table 16. Pharmaceutics and Novel Drug Delivery Systems Market Restraints
    Table 17. Global Pharmaceutics and Novel Drug Delivery Systems Revenue by Players (2019-2024) & (US$ Million)
    Table 18. Global Pharmaceutics and Novel Drug Delivery Systems Revenue Share by Players (2019-2024)
    Table 19. Global Top Pharmaceutics and Novel Drug Delivery Systems by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutics and Novel Drug Delivery Systems as of 2023)
    Table 20. Global Pharmaceutics and Novel Drug Delivery Systems Industry Ranking 2022 VS 2023 VS 2024
    Table 21. Global 5 Largest Players Market Share by Pharmaceutics and Novel Drug Delivery Systems Revenue (CR5 and HHI) & (2019-2024)
    Table 22. Global Key Players of Pharmaceutics and Novel Drug Delivery Systems, Headquarters and Area Served
    Table 23. Global Key Players of Pharmaceutics and Novel Drug Delivery Systems, Product and Application
    Table 24. Global Key Players of Pharmaceutics and Novel Drug Delivery Systems, Product and Application
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2019-2024) & (US$ Million)
    Table 27. Global Pharmaceutics and Novel Drug Delivery Systems Revenue Market Share by Type (2019-2024)
    Table 28. Global Pharmaceutics and Novel Drug Delivery Systems Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 29. Global Pharmaceutics and Novel Drug Delivery Systems Revenue Market Share by Type (2025-2030)
    Table 30. Global Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2019-2024) & (US$ Million)
    Table 31. Global Pharmaceutics and Novel Drug Delivery Systems Revenue Share by Application (2019-2024)
    Table 32. Global Pharmaceutics and Novel Drug Delivery Systems Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 33. Global Pharmaceutics and Novel Drug Delivery Systems Revenue Share by Application (2025-2030)
    Table 34. North America Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2019-2024) & (US$ Million)
    Table 35. North America Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2025-2030) & (US$ Million)
    Table 36. North America Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2019-2024) & (US$ Million)
    Table 37. North America Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2025-2030) & (US$ Million)
    Table 38. North America Pharmaceutics and Novel Drug Delivery Systems Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 39. North America Pharmaceutics and Novel Drug Delivery Systems Market Size by Country (2019-2024) & (US$ Million)
    Table 40. North America Pharmaceutics and Novel Drug Delivery Systems Market Size by Country (2025-2030) & (US$ Million)
    Table 41. Europe Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2019-2024) & (US$ Million)
    Table 42. Europe Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2025-2030) & (US$ Million)
    Table 43. Europe Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2019-2024) & (US$ Million)
    Table 44. Europe Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2025-2030) & (US$ Million)
    Table 45. Europe Pharmaceutics and Novel Drug Delivery Systems Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 46. Europe Pharmaceutics and Novel Drug Delivery Systems Market Size by Country (2019-2024) & (US$ Million)
    Table 47. Europe Pharmaceutics and Novel Drug Delivery Systems Market Size by Country (2025-2030) & (US$ Million)
    Table 48. China Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2019-2024) & (US$ Million)
    Table 49. China Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2025-2030) & (US$ Million)
    Table 50. China Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2019-2024) & (US$ Million)
    Table 51. China Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2025-2030) & (US$ Million)
    Table 52. Asia Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2019-2024) & (US$ Million)
    Table 53. Asia Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2025-2030) & (US$ Million)
    Table 54. Asia Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2019-2024) & (US$ Million)
    Table 55. Asia Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2025-2030) & (US$ Million)
    Table 56. Asia Pharmaceutics and Novel Drug Delivery Systems Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 57. Asia Pharmaceutics and Novel Drug Delivery Systems Market Size by Region (2019-2024) & (US$ Million)
    Table 58. Asia Pharmaceutics and Novel Drug Delivery Systems Market Size by Region (2025-2030) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2019-2024) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2025-2030) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2019-2024) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2025-2030) & (US$ Million)
    Table 63. Middle East, Africa, and Latin America Pharmaceutics and Novel Drug Delivery Systems Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 64. Middle East, Africa, and Latin America Pharmaceutics and Novel Drug Delivery Systems Market Size by Country (2019-2024) & (US$ Million)
    Table 65. Middle East, Africa, and Latin America Pharmaceutics and Novel Drug Delivery Systems Market Size by Country (2025-2030) & (US$ Million)
    Table 66. Amgen Company Details
    Table 67. Amgen Business Overview
    Table 68. Amgen Pharmaceutics and Novel Drug Delivery Systems Product
    Table 69. Amgen Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024) & (US$ Million)
    Table 70. Amgen Recent Developments
    Table 71. Teva Company Details
    Table 72. Teva Business Overview
    Table 73. Teva Pharmaceutics and Novel Drug Delivery Systems Product
    Table 74. Teva Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024) & (US$ Million)
    Table 75. Teva Recent Developments
    Table 76. Roche Company Details
    Table 77. Roche Business Overview
    Table 78. Roche Pharmaceutics and Novel Drug Delivery Systems Product
    Table 79. Roche Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024) & (US$ Million)
    Table 80. Roche Recent Developments
    Table 81. UCB (Union Chimique Belge) Company Details
    Table 82. UCB (Union Chimique Belge) Business Overview
    Table 83. UCB (Union Chimique Belge) Pharmaceutics and Novel Drug Delivery Systems Product
    Table 84. UCB (Union Chimique Belge) Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024) & (US$ Million)
    Table 85. UCB (Union Chimique Belge) Recent Developments
    Table 86. Celgene Company Details
    Table 87. Celgene Business Overview
    Table 88. Celgene Pharmaceutics and Novel Drug Delivery Systems Product
    Table 89. Celgene Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024) & (US$ Million)
    Table 90. Celgene Recent Developments
    Table 91. Merck Company Details
    Table 92. Merck Business Overview
    Table 93. Merck Pharmaceutics and Novel Drug Delivery Systems Product
    Table 94. Merck Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024) & (US$ Million)
    Table 95. Merck Recent Developments
    Table 96. Gilead Sciences Company Details
    Table 97. Gilead Sciences Business Overview
    Table 98. Gilead Sciences Pharmaceutics and Novel Drug Delivery Systems Product
    Table 99. Gilead Sciences Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024) & (US$ Million)
    Table 100. Gilead Sciences Recent Developments
    Table 101. Sanofi Company Details
    Table 102. Sanofi Business Overview
    Table 103. Sanofi Pharmaceutics and Novel Drug Delivery Systems Product
    Table 104. Sanofi Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024) & (US$ Million)
    Table 105. Sanofi Recent Developments
    Table 106. Pfizer Company Details
    Table 107. Pfizer Business Overview
    Table 108. Pfizer Pharmaceutics and Novel Drug Delivery Systems Product
    Table 109. Pfizer Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024) & (US$ Million)
    Table 110. Pfizer Recent Developments
    Table 111. Takeda Company Details
    Table 112. Takeda Business Overview
    Table 113. Takeda Pharmaceutics and Novel Drug Delivery Systems Product
    Table 114. Takeda Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024) & (US$ Million)
    Table 115. Takeda Recent Developments
    Table 116. Bausch&Lomb Company Details
    Table 117. Bausch&Lomb Business Overview
    Table 118. Bausch&Lomb Pharmaceutics and Novel Drug Delivery Systems Product
    Table 119. Bausch&Lomb Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024) & (US$ Million)
    Table 120. Bausch&Lomb Recent Developments
    Table 121. Samyang Biopharmaceuticals Company Details
    Table 122. Samyang Biopharmaceuticals Business Overview
    Table 123. Samyang Biopharmaceuticals Pharmaceutics and Novel Drug Delivery Systems Product
    Table 124. Samyang Biopharmaceuticals Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024) & (US$ Million)
    Table 125. Samyang Biopharmaceuticals Recent Developments
    Table 126. Johnson & Johnson Company Details
    Table 127. Johnson & Johnson Business Overview
    Table 128. Johnson & Johnson Pharmaceutics and Novel Drug Delivery Systems Product
    Table 129. Johnson & Johnson Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024) & (US$ Million)
    Table 130. Johnson & Johnson Recent Developments
    Table 131. TOLMAR Company Details
    Table 132. TOLMAR Business Overview
    Table 133. TOLMAR Pharmaceutics and Novel Drug Delivery Systems Product
    Table 134. TOLMAR Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024) & (US$ Million)
    Table 135. TOLMAR Recent Developments
    Table 136. Astellas Company Details
    Table 137. Astellas Business Overview
    Table 138. Astellas Pharmaceutics and Novel Drug Delivery Systems Product
    Table 139. Astellas Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024) & (US$ Million)
    Table 140. Astellas Recent Developments
    Table 141. AMAG Pharmaceuticals Company Details
    Table 142. AMAG Pharmaceuticals Business Overview
    Table 143. AMAG Pharmaceuticals Pharmaceutics and Novel Drug Delivery Systems Product
    Table 144. AMAG Pharmaceuticals Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024) & (US$ Million)
    Table 145. AMAG Pharmaceuticals Recent Developments
    Table 146. AbbVie Company Details
    Table 147. AbbVie Business Overview
    Table 148. AbbVie Pharmaceutics and Novel Drug Delivery Systems Product
    Table 149. AbbVie Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024) & (US$ Million)
    Table 150. AbbVie Recent Developments
    Table 151. Dr Reddy Company Details
    Table 152. Dr Reddy Business Overview
    Table 153. Dr Reddy Pharmaceutics and Novel Drug Delivery Systems Product
    Table 154. Dr Reddy Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024) & (US$ Million)
    Table 155. Dr Reddy Recent Developments
    Table 156. AstraZeneca Company Details
    Table 157. AstraZeneca Business Overview
    Table 158. AstraZeneca Pharmaceutics and Novel Drug Delivery Systems Product
    Table 159. AstraZeneca Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024) & (US$ Million)
    Table 160. AstraZeneca Recent Developments
    Table 161. Aspen Company Details
    Table 162. Aspen Business Overview
    Table 163. Aspen Pharmaceutics and Novel Drug Delivery Systems Product
    Table 164. Aspen Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024) & (US$ Million)
    Table 165. Aspen Recent Developments
    Table 166. Acrotech Biopharma Company Details
    Table 167. Acrotech Biopharma Business Overview
    Table 168. Acrotech Biopharma Pharmaceutics and Novel Drug Delivery Systems Product
    Table 169. Acrotech Biopharma Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024) & (US$ Million)
    Table 170. Acrotech Biopharma Recent Developments
    Table 171. TWi Pharmaceuticals Company Details
    Table 172. TWi Pharmaceuticals Business Overview
    Table 173. TWi Pharmaceuticals Pharmaceutics and Novel Drug Delivery Systems Product
    Table 174. TWi Pharmaceuticals Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024) & (US$ Million)
    Table 175. TWi Pharmaceuticals Recent Developments
    Table 176. Research Programs/Design for This Report
    Table 177. Key Data Information from Secondary Sources
    Table 178. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Pharmaceutics and Novel Drug Delivery Systems Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Pharmaceutics and Novel Drug Delivery Systems Market Share by Type: 2023 VS 2030
    Figure 3. Liposomes Features
    Figure 4. PEGylated Proteins & Polypeptides Features
    Figure 5. Polymer Nanoparticle Features
    Figure 6. Protein–drug Conjugates Features
    Figure 7. Other Features
    Figure 8. Global Pharmaceutics and Novel Drug Delivery Systems Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 9. Global Pharmaceutics and Novel Drug Delivery Systems Market Share by Application: 2023 VS 2030
    Figure 10. Hospitals & Clinic Case Studies
    Figure 11. Cancer Treatment Centers Case Studies
    Figure 12. Others Case Studies
    Figure 13. Pharmaceutics and Novel Drug Delivery Systems Report Years Considered
    Figure 14. Global Pharmaceutics and Novel Drug Delivery Systems Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 15. Global Pharmaceutics and Novel Drug Delivery Systems Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 16. Global Pharmaceutics and Novel Drug Delivery Systems Market Share by Region: 2023 VS 2030
    Figure 17. Global Pharmaceutics and Novel Drug Delivery Systems Market Share by Players in 2023
    Figure 18. Global Top Pharmaceutics and Novel Drug Delivery Systems Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutics and Novel Drug Delivery Systems as of 2023)
    Figure 19. The Top 10 and 5 Players Market Share by Pharmaceutics and Novel Drug Delivery Systems Revenue in 2023
    Figure 20. North America Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 21. North America Pharmaceutics and Novel Drug Delivery Systems Market Share by Type (2019-2030)
    Figure 22. North America Pharmaceutics and Novel Drug Delivery Systems Market Share by Application (2019-2030)
    Figure 23. North America Pharmaceutics and Novel Drug Delivery Systems Market Share by Country (2019-2030)
    Figure 24. United States Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. Canada Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. Europe Pharmaceutics and Novel Drug Delivery Systems Market Size YoY (2019-2030) & (US$ Million)
    Figure 27. Europe Pharmaceutics and Novel Drug Delivery Systems Market Share by Type (2019-2030)
    Figure 28. Europe Pharmaceutics and Novel Drug Delivery Systems Market Share by Application (2019-2030)
    Figure 29. Europe Pharmaceutics and Novel Drug Delivery Systems Market Share by Country (2019-2030)
    Figure 30. Germany Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. France Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. U.K. Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Italy Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Russia Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. Nordic Countries Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. China Pharmaceutics and Novel Drug Delivery Systems Market Size YoY (2019-2030) & (US$ Million)
    Figure 37. China Pharmaceutics and Novel Drug Delivery Systems Market Share by Type (2019-2030)
    Figure 38. China Pharmaceutics and Novel Drug Delivery Systems Market Share by Application (2019-2030)
    Figure 39. Asia Pharmaceutics and Novel Drug Delivery Systems Market Size YoY (2019-2030) & (US$ Million)
    Figure 40. Asia Pharmaceutics and Novel Drug Delivery Systems Market Share by Type (2019-2030)
    Figure 41. Asia Pharmaceutics and Novel Drug Delivery Systems Market Share by Application (2019-2030)
    Figure 42. Asia Pharmaceutics and Novel Drug Delivery Systems Market Share by Region (2019-2030)
    Figure 43. Japan Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. South Korea Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. China Taiwan Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Southeast Asia Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. India Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. Australia Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 49. Middle East, Africa, and Latin America Pharmaceutics and Novel Drug Delivery Systems Market Size YoY (2019-2030) & (US$ Million)
    Figure 50. Middle East, Africa, and Latin America Pharmaceutics and Novel Drug Delivery Systems Market Share by Type (2019-2030)
    Figure 51. Middle East, Africa, and Latin America Pharmaceutics and Novel Drug Delivery Systems Market Share by Application (2019-2030)
    Figure 52. Middle East, Africa, and Latin America Pharmaceutics and Novel Drug Delivery Systems Market Share by Country (2019-2030)
    Figure 53. Brazil Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Mexico Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Turkey Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Saudi Arabia Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. Israel Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 58. GCC Countries Pharmaceutics and Novel Drug Delivery Systems Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 59. Amgen Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024)
    Figure 60. Teva Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024)
    Figure 61. Roche Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024)
    Figure 62. UCB (Union Chimique Belge) Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024)
    Figure 63. Celgene Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024)
    Figure 64. Merck Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024)
    Figure 65. Gilead Sciences Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024)
    Figure 66. Sanofi Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024)
    Figure 67. Pfizer Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024)
    Figure 68. Takeda Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024)
    Figure 69. Bausch&Lomb Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024)
    Figure 70. Samyang Biopharmaceuticals Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024)
    Figure 71. Johnson & Johnson Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024)
    Figure 72. TOLMAR Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024)
    Figure 73. Astellas Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024)
    Figure 74. AMAG Pharmaceuticals Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024)
    Figure 75. AbbVie Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024)
    Figure 76. Dr Reddy Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024)
    Figure 77. AstraZeneca Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024)
    Figure 78. Aspen Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024)
    Figure 79. Acrotech Biopharma Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024)
    Figure 80. TWi Pharmaceuticals Revenue Growth Rate in Pharmaceutics and Novel Drug Delivery Systems Business (2019-2024)
    Figure 81. Bottom-up and Top-down Approaches for This Report
    Figure 82. Data Triangulation
    Figure 83. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

Global Pharmaceutical Drug Delivery Technologies Market Insights Forecast to 2030
Global Pharmaceutical Drug Delivery Devices Market Insights Forecast to 2030
Novel Vaccine Delivery Systems Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Targeted Drug Delivery System Market Research Report 2025
Global Nanotechnology based Drug Delivery Systems Market Research Report 2024
Global Nano based Drug Delivery System Market Research Report 2024
Global Novel Drug Delivery Systems Market Research Report 2025
Global Colon Targeted Drug Delivery Systems Market Insights Forecast to 2030
Global Biopharmaceutical Drug Delivery Technologies Market Research Report 2024
Novel Drug Delivery Systems for Cancer Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Drug Delivery Technology Market Research Report 2024
Global Drug Delivery in Cancer Market Insights Forecast to 2030
Injectable Drug Delivery Systems Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Liposome Assisted Drug Delivery Market Insights Forecast to 2030
Global Novel Cardiovascular Drug Delivery Devices Market Research Report 2024
Global Nanotechnology in Targeted Drug Delivery Market Research Report 2024
Global Medicine Delivery Devices Market Research Report 2024
Global Drug Discovery Technologies Market Insights Forecast to 2030
Global Nanoparticle Drug Delivery System Market Research Report 2024
Nanotechnology Drug Delivery Systems Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions